CoChat

Emerging Roles of Complement Protein C1q in Neurodegeneration

Cho, Kyoungjoo · 2019 · Aging and disease
Cited by 72

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14336/ad.2019.0118

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 21 references

Research works printed but not linked: 79

  1. Woodruff TM, Nandakumar KS, Tedesco F (2011). Inhibiting the C5-C5a receptor axis. Mol Immunol, 48:1631-1642. · DOI · Paper page
  2. Sim RB, Laich A (2000). Serine proteases of the complement system. Biochem Soc Trans, 28:545-550. · DOI
  3. Reid KBM (2018). Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual, Serum Protein. Front Immunol, 9:764. · DOI
  4. Conti P, Shaik-Dasthagirisaheb YB (2015). Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders. Neurotox Res, 28:147-153. · DOI
  5. Nayak A, Ferluga J, Tsolaki AG, Kishore U (2010). The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett, 131:139-150. · DOI
  6. Cho KJ, Cheon SY, Kim GW (2016). Apoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q. Sci Rep, 6:18840. · DOI
  7. Francis K, van Beek J, Canova C, Neal JW, Gasque P (2003). Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med, 5:1-19. · DOI · Paper page
  8. Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V (2002). Structural biology of C1. Biochem Soc Trans, 30:1001-1006. · DOI
  9. Rabs U, Martin H, Hitschold T, Golan MD, Heinz HP, Loos M (1986). Isolation and characterization of macrophage-derived C1q and its similarities to serum C1q. Eur J Immunol, 16:1183-1186. · DOI
  10. De Bracco MM, Manni JA (1974). Serum levels of C1q, C1r and C1s in normal and pathologic sera. Arthritis Rheum, 17:121-128. · doi:10.1002/art.1780170204
  11. Knobel HR, Villiger W, Isliker H (1975). Chemical analysis and electron microscopy studies of human C1q prepared by different methods. Eur J Immunol, 5:78-82. · doi:10.1002/eji.1830050119
  12. Brodsky-Doyle B, Leonard KR, Reid KB (1976). Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J, 159:279-286. · DOI · Paper page
  13. Kishore U, Ghai R, Greenhough TJ, Shrive AK, Bonifati DM, Gadjeva MG, et al. (2004). Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett, 95:113-128. · DOI · Paper page
  14. Gaboriaud C, Teillet F, Gregory LA, Thielens NM, Arlaud GJ (2007). Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights. Immunobiology, 212:279-288. · doi:10.1016/j.imbio.2006.11.007
  15. Ghebrehiwet B, Hosszu KH, Peerschke EI (2017). C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol, 84:26-33. · DOI
  16. Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, Reid KB, et al. (2004). C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol, 25:551-561. · DOI · Paper page
  17. Sim RB, Kishore U, Villiers CL, Marche PN, Mitchell DA (2007). C1q binding and complement activation by prions and amyloids. Immunobiology, 212:355-362. · DOI · Paper page
  18. Kakegawa W, Mitakidis N, Miura E, Abe M, Matsuda K, Takeo YH, et al. (2015). Anterograde C1ql1 signaling is required in order to determine and maintain a single-winner climbing fiber in the mouse cerebellum. Neuron, 85:316-329. · DOI · Paper page
  19. Lei X, Seldin MM, Little HC, Choy N, Klonisch T, Wong GW (2017). C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem, 292:14836-14850. · DOI · Paper page
  20. Beraudi A, Stea S, Bordini B, Baleani M, Viceconti M (2010). Osteon classification in human fibular shaft by circularly polarized light. Cells Tissues Organs, 191:260-268. · DOI
  21. Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B (2006). Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol Immunol, 43:1402-1407. · DOI
  22. Leigh LE, Ghebrehiwet B, Perera TP, Bird IN, Strong P, Kishore U, et al. (1998). C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J, 330 (Pt 1):247-254. · DOI
  23. Hooshmand MJ, Nguyen HX, Piltti KM, Benavente F, Hong S, Flanagan L, et al. (2017). Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis. J Immunol, 199:1069-1085. · DOI
  24. Kantrow SP, Shen Z, Jagneaux T, Zhang P, Nelson S (2009). Neutrophil-mediated lung permeability and host defense proteins. Am J Physiol Lung Cell Mol Physiol, 297:L738-745. · DOI
  25. Perry VH, O’Connor V (2008). C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci, 9:807-811. · DOI
  26. Goodman EB, Anderson DC, Tenner AJ (1995). C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J Leukoc Biol, 58:168-176. · DOI
  27. Lood C, Eriksson S, Gullstrand B, Jonsen A, Sturfelt G, Truedsson L, et al. (2012). Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis? Lupus, 21:1423-1432. · DOI · Paper page
  28. Madhukaran SP, Alhamlan FS, Kale K, Vatish M, Madan T, Kishore U (2016). Role of collectins and complement protein C1q in pregnancy and parturition. Immunobiology, 221:1273-1288. · DOI
  29. Xiao J, Li Y, Gressitt KL, He H, Kannan G, Schultz TL, et al. (2016). Cerebral complement C1q activation in chronic Toxoplasma infection. Brain Behav Immun, 58:52-56. · DOI
  30. Datwani A, McConnell MJ, Kanold PO, Micheva KD, Busse B, Shamloo M, et al. (2009). Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron, 64:463-470. · DOI · Paper page
  31. Cherubini E, Caiati MD, Sivakumaran S (2011). In the developing hippocampus kainate receptors control the release of GABA from mossy fiber terminals via a metabotropic type of action. Adv Exp Med Biol, 717:11-26. · DOI
  32. Williams PA, Tribble JR, Pepper KW, Cross SD, Morgan BP, Morgan JE, et al. (2016). Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener, 11:26. · DOI · Paper page
  33. Stephan AH, Barres BA, Stevens B (2012). The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci, 35:369-389. · DOI · Paper page
  34. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. (2016). Schizophrenia risk from complex variation of complement component 4. Nature, 530:177-183. · DOI · Paper page
  35. Harry GJ (2013). Microglia during development and aging. Pharmacol Ther, 139:313-326. · DOI · Paper page
  36. Guido W (2008). Refinement of the retinogeniculate pathway. J Physiol, 586:4357-4362. · DOI · Paper page
  37. Hong YK, Chen C (2011). Wiring and rewiring of the retinogeniculate synapse. Curr Opin Neurobiol, 21:228-237. · DOI · Paper page
  38. Chen C, Regehr WG (2000). Developmental remodeling of the retinogeniculate synapse. Neuron, 28:955-966. · DOI · Paper page
  39. Jaubert-Miazza L, Green E, Lo FS, Bui K, Mills J, Guido W (2005). Structural and functional composition of the developing retinogeniculate pathway in the mouse. Vis Neurosci, 22:661-676. · DOI · Paper page
  40. Torborg CL, Feller MB (2004). Unbiased analysis of bulk axonal segregation patterns. J Neurosci Methods, 135:17-26. · DOI
  41. McLin VA, Hu CH, Shah R, Jamrich M (2008). Expression of complement components coincides with early patterning and organogenesis in Xenopus laevis. Int J Dev Biol, 52:1123-1133. · DOI
  42. Li X, Madison BB, Zacharias W, Kolterud A, States D, Gumucio DL (2007). Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk. Physiol Genomics, 29:290-301. · DOI
  43. Ma Y, Ramachandran A, Ford N, Parada I, Prince DA (2013). Remodeling of dendrites and spines in the C1q knockout model of genetic epilepsy. Epilepsia, 54:1232-1239. · DOI · Paper page
  44. Cortes JR, Sanchez-Diaz R, Bovolenta ER, Barreiro O, Lasarte S, Matesanz-Marin A, et al. (2014). Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression. J Autoimmun, 55:51-62. · DOI
  45. Kannan G, Crawford JA, Yang C, Gressitt KL, Ihenatu C, Krasnova IN, et al. (2016). Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii. Neurobiol Dis, 91:307-314. · DOI
  46. Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J (2004). Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem, 279:46907-46914. · DOI · Paper page
  47. Mallucci GR (2009). Prion neurodegeneration: starts and stops at the synapse. Prion, 3:195-201. · DOI
  48. Selkoe DJ (2002). Alzheimer’s disease is a synaptic failure. Science, 298:789-791. · DOI · Paper page
  49. Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. (2015). Emerging and Novel Functions of Complement Protein C1q. Front Immunol, 6:317. · DOI · Paper page
  50. Farber K, Cheung G, Mitchell D, Wallis R, Weihe E, Schwaeble W, et al. (2009). C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res, 87:644-652. · DOI · Paper page
  51. Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, et al. (2004). Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol, 40:709-716. · DOI
  52. Veerhuis R, Boshuizen RS, Morbin M, Mazzoleni G, Hoozemans JJ, Langedijk JP, et al. (2005). Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q. Neurobiol Dis, 19:273-282. · DOI
  53. Fraser DA, Pisalyaput K, Tenner AJ (2010). C1q enhances microglial clearance of apoptotic neurons and neuronal blebs and modulates subsequent inflammatory cytokine production. J Neurochem, 112:733-743. · DOI · Paper page
  54. Rambach G, Maier H, Vago G, Mohsenipour I, Lass-Florl C, Defant A, et al. (2008). Complement induction and complement evasion in patients with cerebral aspergillosis. Microbes Infect, 10:1567-1576. · doi:10.1016/j.micinf.2008.09.011
  55. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM, Jr., et al. (2001). Inflammatory repertoire of Alzheimer’s disease and nondemented elderly microglia in vitro. Glia, 35:72-79. · DOI · Paper page
  56. Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, et al. (2014). Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun, 2:53. · DOI · Paper page
  57. Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M (2000). Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol, 12:1015-1023. · DOI · Paper page
  58. Fan R, Tenner AJ (2004). Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures. Exp Neurol, 185:241-253. · DOI · Paper page
  59. Pisalyaput K, Tenner AJ (2008). Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem, 104:696-707. · DOI · Paper page
  60. Benoit ME, Tenner AJ (2011). Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci, 31:3459-3469. · DOI
  61. Rupprecht TA, Angele B, Klein M, Heesemann J, Pfister HW, Botto M, et al. (2007). Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol, 178:1861-1869. · DOI · Paper page
  62. Cai Q, Li Y, Pei G (2017). Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation, 14:63. · DOI
  63. Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, et al. (2017). Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest, 46:816-832. · DOI
  64. Whitelaw BS (2018). Microglia-mediated synaptic elimination in neuronal development and disease. J Neurophysiol, 119:1-4. · DOI · Paper page
  65. Claasen AM, Guevremont D, Mason-Parker SE, Bourne K, Tate WP, Abraham WC, et al. (2009). Secreted amyloid precursor protein-alpha upregulates synaptic protein synthesis by a protein kinase G-dependent mechanism. Neurosci Lett, 460:92-96. · DOI
  66. Kishore U, Gupta SK, Perdikoulis MV, Kojouharova MS, Urban BC, Reid KB (2003). Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol, 171:812-820. · DOI
  67. Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, et al. (2008). Amyloid beta oligomers (A beta (1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci, 28:788-797. · DOI · Paper page
  68. Depboylu C, Schafer MK, Arias-Carrion O, Oertel WH, Weihe E, Hoglinger GU (2011). Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol, 70:125-132. · DOI · Paper page
  69. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. (2005). Microglial activation and dopamine terminal loss in early Parkinson’s disease. Ann Neurol, 57:168-175. · DOI · Paper page
  70. Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC (2002). Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease. J Neurochem, 82:615-624. · DOI · Paper page
  71. Zhang ET, Richards HK, Kida S, Weller RO (1992). Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol, 83:233-239. · DOI · Paper page
  72. Hochmeister S, Zeitelhofer M, Bauer J, Nicolussi EM, Fischer MT, Heinke B, et al. (2008). After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream. Am J Pathol, 173:1669-1681. · DOI
  73. Yamada T, McGeer PL, McGeer EG (1992). Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins. Acta Neuropathol, 84:100-104. · DOI · Paper page
  74. Singhrao SK, Neal JW, Morgan BP, Gasque P (1999). Increased complement biosynthesis by microglia and complement activation on neurons in Huntington’s disease. Exp Neurol, 159:362-376. · DOI · Paper page
  75. Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, et al. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature, 399:263-267. · DOI · Paper page
  76. Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med, 205:1869-1877. · DOI · Paper page
  77. Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, et al. (2007). Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res, 6:2833-2840. · DOI · Paper page
  78. Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, et al. (2011). Abnormal peripheral chemokine profile in Huntington’s disease. PLoS Curr, 3:RRN1231. · DOI · Paper page
  79. Crocker SF, Costain WJ, Robertson HA (2006). DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington’s mice (R6/2) reveals neuroinflammation and insulin associations. Brain Res, 1088:176-186. · DOI

Cited by

See all 72

Metadata

Authors
Cho, K.
Venue
Aging and disease
Published
2019
Volume
10
Issue
3
Pages
652
ISSN
2152-5250
Cited by
72
References
21
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging Roles of Complement Protein C1q in Neurodegeneration. https://app.cochat.ai/papers/10.14336/ad.2019.0118
The paper
Cho, K. (2019). Emerging Roles of Complement Protein C1q in Neurodegeneration. Aging and disease. https://doi.org/10.14336/ad.2019.0118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.